Lupus Clinical Trials in Chicago

Showing 81-100 of 248 trials

Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea

NCT00696111

The purpose of this study is to look at the metabolic (use of energy) and hormonal features of sleep problems in women with polycystic ovary syndrome (PCOS).

Polycystic Ovary SyndromeObstructive Sleep Apnea

University of Chicago18 participantsStarted Dec 2007

Chicago, Illinois, United States

TERMINATEDPhase 22.2 miles

Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus

NCT04680637

The primary objective is to evaluate the efficacy and safety of efavaleukin alfa in subjects with active systemic lupus erythematosus.

Active Systemic Lupus Erythematosus

Amgen168 participantsStarted May 2021

Birmingham, Alabama, United States • Gilbert, Arizona, United States • Glendale, Arizona, United States +147 more locations

Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea

Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus

Lupus Trials in Other Cities

Sleep for Inpatients: Empowering Staff to Act

Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities

A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State

Single Ascending Dose Study of AMG 570 in Healthy Subjects

Pediatric Adenotonsillectomy Trial for Snoring

A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Belimumab Assessment of Safety in SLE

Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea

North American Prodromal Synucleinopathy Consortium

Study Using Negative Pressure to Reduce Apnea

A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)

A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus

Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study

Study of VIB7734 for the Treatment of Moderate to Severely Active SLE

IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis

A Study of Guselkumab in Participants With Active Lupus Nephritis

A Study of Imvotamab in Severe Systemic Lupus Erythematosus

Other Conditions in Chicago